News and Important Dates 

In this time of global uncertainty, we appreciate the severity of this evolving situation as well as it's financial and emotional impact. The Board is working to alleviate your concerns about certification and methods to keep yourself and your patients healthy. Please contact us with any concerns and we will be updating our website regularly. 

Cancellation of the 2020 Joint IAA & BMF Conference and Other CE Events 

The BCCA Board is aware of the impact of cancellation of global conferences on credits towards certification. The Board is reviewing options to assist CCAs with credit shortfall  concerns with maintaining certification. The Board will communicate how we address this issue via email in the near future.

The next CCA Application for Eligibility to sit for the exam is
 January 4, 2021.

The BCCA suggests that candidates planning to submit an application for the January 4, 2021 contact the BCCA administrator ahead of time so we can help the candidate be sure that all the required documents are submitted and the application is completed and on time.

CCA Applications who applied by January 15, 2019  have the following upcoming deadlines.

  • March 1 2021: Confirmation notices are sent to eligible applicants with exam registration instructions and the CCA Examination Registration Form.

  • April 1, 2021: The CCA Examination Registration Form and $800 fee are due to the BCCA.

  • April 15, 2021: An Authorization-to-Test (ATT) is sent to eligible candidates for the CCA administration.

  • May/June 2021 Exam Date TBD: CCA Exam Administration location will be announced

©2020 Board For Certification in Clinical Anaplastology 
6708 Senecca Lane, Sykesville, MD 21784

All materials posted on this site are subject to copyrights owned by the Board For Certification in Clinical Anaplastology.  All other reproduction, retransmission, or reprinting of all or part of any document found on this site are expressly prohibited unless the Board For Certification in Clinical Anaplastology has expressly granted its prior written consent to reproduce, retransmit, or reprint the material. All other rights are reserved.